found that Roxadustat significantly improved the cardiac function of mice after myocardial infarction and reduced the adverse left ventricular remodeling by up-regulating HIF-1α and its downstream cxcl12/cxcr4/ackr3 axis. This evidence concerns the gene HIF1A and myocardial infarction.